Outcomes of coronary artery bypass grafting in patients with connective tissue diseases

Thomas J Birdas1, Jeffrey T Landis, David Haybron

  • 1Department of Cardiothoracic Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA. tbirdas1@aol.com

Insights

Coronary artery bypass grafting (CABG) is safe for patients with connective tissue diseases, offering good early survival. However, wound complications and need for reintervention are more common in this group.

Area of Science:

  • Cardiology
  • Rheumatology
  • Surgical Outcomes

Background:

  • Connective tissue diseases (CTDs) are associated with significant coronary artery disease (CAD) burden.
  • Limited data exists on surgical management outcomes for CTD patients with CAD.

Purpose of the Study:

  • To evaluate the safety and efficacy of coronary artery bypass grafting (CABG) in patients with CTDs.
  • To compare outcomes of CABG in CTD patients with a general surgical population.

Main Methods:

  • Retrospective review of 44 CTD patients undergoing CABG (1995-2002).
  • Demographic, perioperative, and postoperative data collected.
  • Comparison with The Society of Thoracic Surgeons database.

Main Results:

  • CTD patients were more likely women, used immunomodulating agents, and presented with severe angina (CCS Class IV).
  • Higher incidence of inotropic agent use, intraaortic balloon pump, blood transfusions, and leg wound infections observed.
  • Steroid/immunomodulating agent use correlated with increased postoperative complications.
  • 3-year overall survival was 89%; freedom from reintervention was 75%.

Conclusions:

  • CABG is a safe treatment for CTD patients with acceptable early outcomes.
  • Increased risk of wound complications and need for reintervention noted in CTD population.
  • Midterm results suggest less favorable outcomes compared to the general population.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...